Ophthalmology Times: September 2022
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Q&A: What’s in the glaucoma treatment pipeline?
2
FDA grants single-patient expanded access for urcosimod in neuropathic corneal pain
3
SpyGlass Pharma randomizes first patients in 2 phase 3 clinical trials of the BIM-IOL System
4
Sneak peek: What’s ahead at the second International Glaucoma Symposium in Mainz, Germany
5